L-R: Emily Nikolić, Agathe Michel-de Cazotte, Daniel Wise from Carpmaels & Ransford.

16 July 2024NewsUnified Patent CourtMarisa Woutersen

Sanofi and Regeneron triumph in UPC decision against Amgen

UPC’s Munich Central Division revokes Amgen's patent | Decision stems from a revocation action initiated by Sanofi last year | Court's ruling focused on interpretations of patent claims and principles of inventive step.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Unified Patent Court

Most active firms at UPC revealed in report on court’s first year

11 July 2024 Top ten UPC law firms handled over 70% of cases filed at the court | Full list of most prolific plaintiffs and defendants named.

Unified Patent Court

UPC’s second infringement decision revokes patent in Europe

9 July 2024 Pan-European court hands down second infringement decision | Revokes patent Europe-wide after counterclaim | DexCom and Abbott dispute over technology for remotely monitoring blood glucose levels in diabetes patients.

Americas

Sanofi, Regeneron prevail against Amgen at EPO

30 October 2020 French drugmaker Sanofi and US biotechnology company Regeneron have secured a victory at the European Patent Office, which has sided in their favour by ruling that a patent belonging to rival Amgen is invalid.